Swoop extends beyond engagement to impact — helping life sciences companies improve patient outcomes

New York, NY, May 26, 2026 — Swoop, a leader in AI-driven, data-powered, and privacy-compliant healthcare engagement, today announced the acquisition of Nimble, a leading prescription management platform. Across independent pharmacies in all 50 states, Nimble enables 16 million patients to fill, refill, pay for, and manage prescriptions through a seamless, digital-first experience.  

Swoop’s portfolio of solutions enables life sciences companies to reach the right patients and healthcare providers (HCPs), accelerate therapy adoption, and drive meaningful real-world outcomes while maintaining the highest standards of privacy and compliance. This acquisition strengthens Swoop’s ability to improve patient outcomes by connecting aggregated insights and privacy-safe technologies to determine patient needs.  

“Nimble accelerates our ability to connect the signals that drive patient and physician behavior directly to real-world action,” said Swoop CEO and Co-Founder Ron Elwell. “By bringing prescription fulfillment into Swoop, we are extending our platform beyond engagement to impact — helping life sciences companies improve patient outcomes.” 

Accelerating improved patient outcomes with privacy-safe solutions 

Through a powerful product suite, Nimble accelerates the health journey by helping patients start treatment without delays and stay on the therapy programs prescribed by their doctors without disruption. Its platform simplifies prescription access and improves fulfillment efficiency. With Swoop’s reach and resources now supporting Nimble, pharmacies on the platform will benefit from stronger patient engagement, and patients will receive more consistent support. 

“Independent pharmacies are where patient care gets real — they’re the last mile between a prescription and a patient who actually stays on therapy,” said Talha Sattar, Founder and CEO of Nimble. “Joining Swoop gives Nimble pharmacies a meaningful edge in closing that gap, and that’s good for their business and good for the patients who depend on them.” 

Adding Nimble advances Swoop’s position as the only integrated ecosystem built to connect patients and HCPs with the right information to improve health outcomes. Swoop’s footprint now spans audience intelligence, community engagement, AI-powered web solutions, coordinated omnichannel activation, and prescription management. 

“Nimble extends Swoop into prescription fulfillment and adherence. By using privacy-safe, consented, and aggregated signals to indicate patient needs we can help consumers move beyond awareness to action,” said Swoop President Scott Rines. “By integrating these real-time pharmacy signals into our broader engagement ecosystem, we can further help life sciences companies deliver stronger health andcommercial outcomes.”  

This expansion marks the next step in Swoop’s evolution, strengthening its ability to connect HCP and patient marketing channels, improve patient outcomes, and deliver measurable commercial impact during moments that matter most. 

Contact:  
Marcella Milliet Sciorra  
Chief Marketing Officer  
[email protected] 

—- 
 
About Nimble, a Swoop company 
Nimble, a Swoop company, enables people to live their best lives by improving access, understanding, and management of their healthcare. The technology helps independent and regional pharmacies deliver the best possible care to their communities by modernizing pharmacy workflows. It simplifies everything from mobile checkout and prescription fills/refills to patient communications. By dismantling the barriers to consistent care, Nimble’s digital interventions drive significant impact, improving medication adherence by 26-40 percent while freeing pharmacists from busy work so they can spend more time on patient care. 

As part of Swoop’s privacy-by-design approach, Nimble’s prescription fulfillment data integrates into an exclusive commercial intelligence layer. These signals enable life sciences companies to accelerate therapy adoption, support long-term adherence, and drive measurable impact across the treatment lifecycle.